Physician profile
Erbert Caceres
NPI 1508976788
$6,258.63
in general payments reported to CMS, 2019-2025
34 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,276 · 2020: $86.80 · 2021: $137 · 2022: $665 · 2023: $2,414 · 2024: $1,513 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,973 · Travel and Lodging: $1,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,972.64 |
| Travel and Lodging | $1,120.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,908.68 | 2019-2025 | Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Amgen INC. | $639.38 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $632.19 | 2019-2024 | Xarelto |
| Abiomed | $357.89 | 2022-2024 | Impella |
| Abbott Laboratories | $346.02 | 2019-2024 | Esprit, Cardiomems |
| Novartis Pharmaceuticals Corporation | $285.81 | 2019-2024 | |
| Penumbra, INC. | $283.05 | 2024 | Penumbra System, Indigo System |
| Shockwave Medical, INC | $268.48 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $136.06 | 2019-2024 | |
| Endologix LLC | $134.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $127.60 | 2019-2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $121.79 | 2019-2023 | Farxiga |
| Novo Nordisk INC | $119.50 | 2024-2025 | Wegovy |
| Philips North America LLC | $103.49 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $96.59 | 2019-2023 | Camzyos, Eliquis |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $92.28 | 2019 | |
| Biotronik INC. | $72.60 | 2020-2022 | |
| Bard Peripheral Vascular, INC. | $69.00 | 2019 | |
| Edwards Lifesciences Corporation | $63.65 | 2023-2024 | Sapien 3 Ultra Resilia |
| Biosense Webster, INC. | $55.83 | 2023-2024 | Carto 3 |
| Cardiovascular Systems INC. | $50.74 | 2019-2023 | Diamondback Coronary |
| Livanova USA, INC. | $48.63 | 2019 | |
| Welch Allyn | $42.38 | 2019 | |
| Getinge USA Sales, LLC | $33.68 | 2019 | |
| Medtronic Vascular, INC. | $32.34 | 2019 | |
| Terumo Medical Corporation | $24.01 | 2024 | Heartrail |
| Recor Medical INC | $17.49 | 2024 | Paradise Renal Denervation System |
| Siemens Medical Solutions USA, INC. | $17.01 | 2025 | Acuson Origin Diagnostic Ultrasound System |
| Cardinal Health 200 LLC | $15.29 | 2019 | |
| Cook Medical LLC | $14.20 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $13.13 | 2019 | |
| Amarin Pharma, INC. | $12.37 | 2021 | |
| Teleflex LLC | $11.78 | 2019 | |
| Medtronic, INC. | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erbert Caceres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.